Paloma Partners Management CO Amarin Corp Plcuk Transaction History

Paloma Partners Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.85 - $3.73 $106,983 - $140,016	-37,538 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $121,623 - $194,446	37,538 New	37,538 $127,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $643,205 - $1.11 Million	-46,141 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $640,898 - $1.07 Million	46,141 New	46,141 $699,000
Q2 2018 Aug 14, 2018	SELL	$2.68 - $3.48 $34,170 - $44,370	-12,750 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.99 - $4.44 $67,017 - $99,518	-22,414 Reduced 63.74%	12,750 $38,000
Q4 2017 Feb 14, 2018	BUY	$3.06 - $4.09 $107,601 - $143,820	35,164	35,164 $141,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.